Publications

• Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study.

  (Goldberg AD, Atallah E, Rizzieri D, Walter RB, Chung KY, Spira A, Stock W, Tallman MS, Cruz HG, Boni J, Havenith KEG, Chao G, Feingold JM, Wuerthner J, Solh M.) Leuk Res. 2020 08;95:106385 PMID: 32521310 SCOPUS ID: 2-s2.0-85085967271 06/11/2020

• Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin.

  (Badar T, Szabo A, Wadleigh M, Liedtke M, Arslan S, Siebenaller C, Aldoss I, Schultz E, Hefazi M, Litzow MR, Kuo E, Wang A, Curran E, Shallis RM, Podoltsev N, Balasubramanian S, Yang J, Mattison R, Burkart M, Dinner S, Advani A, Atallah E.) Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):556-560.e2 PMID: 32291234 SCOPUS ID: 2-s2.0-85083004098 04/16/2020

• Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase-A real world study.

  (George G, Rezazadeh A, Zook F, Pearl N, McCoy C, Carlson K, Runaas L, Abedin S, Guru Murthy GS, Michaelis LC, Atallah E, Baumann-Kreuziger L.) Leuk Res. 2020 07;94:106368 PMID: 32442786 SCOPUS ID: 2-s2.0-85084755644 05/23/2020

• Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab.

  (Badar T, Szabo A, Advani A, Wadleigh M, Arslan S, Khan MA, Aldoss I, Siebenaller C, Schultz E, Hefazi M, Shallis RM, Yurkiewicz I, Podoltsev N, Patel AA, Curran E, Balasubramanian S, Yang J, Mattison RJ, Burkart M, Dinner S, Liedtke M, Litzow MR, Atallah E.) Blood Adv. 2020 May 26;4(10):2308-2316 PMID: 32453836 PMCID: PMC7252553 SCOPUS ID: 2-s2.0-85086878601 05/27/2020

• In Reply.

  (Flynn KE, Vanness DJ, Myers JM, D'Souza A, Schiffer CA, Thompson JE, Atallah E.) Oncologist. 2020 04;25(4):e744-e745 PMID: 31873972 PMCID: PMC7160403 SCOPUS ID: 2-s2.0-85076804489 12/25/2019

• Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study.

  (Atallah E, Logan B, Chen M, Cutler C, Deeg J, Jacoby M, Champlin R, Nishihori T, Confer D, Gajewski J, Farnia S, Greenberg P, Warlick E, Weisdorf D, Saber W, Horowitz MM, Rizzo JD.) JAMA Oncol. 2020 Apr 01;6(4):486-493 PMID: 31830234 PMCID: PMC6990739 SCOPUS ID: 2-s2.0-85076620276 12/13/2019

• Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia.

  (Jain N, Stock W, Zeidan A, Atallah E, McCloskey J, Heffner L, Tomlinson B, Bhatnagar B, Feingold J, Ungar D, Chao G, Zhang X, Qin Y, Havenith K, Kantarjian H, Wieduwilt MJ.) Blood Adv. 2020 02 11;4(3):449-457 PMID: 32012214 PMCID: PMC7013258 SCOPUS ID: 2-s2.0-85082200332 02/06/2020

• Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.

  (Guru Murthy GS, Szabo A, Michaelis L, Carlson KS, Runaas L, Abedin S, Atallah E.) J Natl Compr Canc Netw. 2020 02;18(2):169-175 PMID: 32023530 SCOPUS ID: 2-s2.0-85079065513 02/06/2020

• Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study

  (Goldberg AD, Atallah E, Rizzieri D, Walter RB, Chung KY, Spira A, Stock W, Tallman MS, Cruz HG, Boni J, Havenith KEG, Chao G, Feingold JM, Wuerthner J, Solh M.) Leukemia Research. August 2020;95 SCOPUS ID: 2-s2.0-85085967271 08/01/2020

• Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase—A real world study

  (George G, Rezazadeh A, Zook F, Pearl N, McCoy C, Carlson K, Runaas L, Abedin S, Guru Murthy GS, Michaelis LC, Atallah E, Baumann-Kreuziger L.) Leukemia Research. July 2020;94 SCOPUS ID: 2-s2.0-85084755644 07/01/2020

• Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Tyrosine Kinase Inhibitor Therapy Cessation.

  (Kota V, Atallah E.) Clin Lymphoma Myeloma Leuk. 2019 08;19(8):480-487 PMID: 31171474 SCOPUS ID: 2-s2.0-85066428575 06/07/2019

• Patients' perspectives on the definition of cure in chronic myeloid leukemia.

  (Flynn KE, Mauro MJ, George G, Hinman A, Baim A, Kota V, Larson RA, Lipton JH, Thompson JE, Wadleigh M, Atallah E.) Leuk Res. 2019 05;80:40-42 PMID: 30955853 SCOPUS ID: 2-s2.0-85063942202 04/09/2019